News

Tennessee based, Cumberland has announced that FDA has approved Caldolor, an intravenous formulation of ibuprofen, through a priority review. Caldolor is indicated for the management of mild to

New Jersey-based Merck has issued the following statement in response to the FDA’s updated information on leukotriene inhibitors, including Singulair (montelukast sodium). Since the introduction of Singulair, the

Bayer Schering Pharma has completed its first global phase-II study analyzing the sensitivity and specificity of BAY 94-9172 (AV1/ZK). The study used positron emission tomography (PET) in patients

Novartis has produced its first batch of experimental swine flu vaccine. Swine flu was declared pandemic by WHO on Thursday, June 11, 2009. The vaccine was produced at

Biosense has declared that it will be part of a public/private collaboration to fund a global clinical trial, to compare catheter ablation to medical therapy in treating atrial

Abraxis Bioscience has launched Abraxane for Injectable Suspension in China, for the treatment of patients with metastatic breast cancer. In a global phase-III clinical trial, and in phase-II

Bristol-Myers Squibb has announced the results of two Orencia (abatacept) studies at the 2009 Annual European Congress of Rheumatology (EULAR), in Copenhagen, Denmark. Orencia is a selective co-stimulation

Baxter has announced that it has completed testing and evaluation of the A (H1N1) influenza virus, and is now in full-scale production stage using its Vero cell culture

Sanofi Pasteur, the vaccines division of Sanofi-Aventis, has announced that it is ready to support public health efforts to tackle the emergence of the new A(H1N1) influenza strain.